Immunodeficiency Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Immunodeficiency stocks.

Immunodeficiency Stocks Recent News

Date Stock Title
May 15 GILD Gilead Sciences, Inc. (GILD) RBC Capital Markets Global Healthcare Conference (Transcript)
May 15 INO Inovio Pharmaceuticals, Inc. (INO) Presents at 2024 RBC Capital Markets Global Healthcare Conference (Transcript)
May 15 AEMD Aethlon Medical announces pricing of $4.7 million public offering
May 15 AEMD Aethlon Medical Announces Pricing of $4.7 Million Public Offering
May 15 AEMD Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
May 15 NNVC NanoViricides GAAP EPS of -$0.16
May 15 NNVC NanoViricides Has Filed its Quarterly Report
May 14 INO Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference (Transcript)
May 14 GILD Gilead Sciences, Inc. (GILD) BofA Securities 2024 Health Care Conference (Transcript)
May 14 GILD Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
May 14 GILD Gilead Sciences: Native Health Navigator Program Connects Tribes to Cancer Care
May 14 NNVC A Novel Broad-Spectrum Antiviral with Activity Against RSV
May 14 INO Inovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 14 INO Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript
May 13 INO Inovio Pharmaceuticals, Inc. (INO) Q1 2024 Earnings Call Transcript
May 13 INO Inovio Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 13 INO Inovio Pharmaceuticals GAAP EPS of -$1.31 misses by $0.31
May 13 INO INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 13 BMY Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript)
May 13 GILD One stock is dragging down the S&P 500's earnings growth
Immunodeficiency

Immunodeficiency, also known as immunocompromisation, is a state in which the immune system's ability to fight infectious diseases and cancer is compromised or entirely absent. Most cases are acquired ("secondary") due to extrinsic factors that affect the patient's immune system. Examples of these extrinsic factors include HIV infection and environmental factors, such as nutrition.
Immunocompromisation may also be due to genetic diseases/flaws. An example here is SCID.
In clinical settings, immunosuppression by some drugs, such as steroids, can either be an adverse effect or the intended purpose of the treatment. Examples of such use is in organ transplant surgery as an anti-rejection measure and in patients suffering from an overactive immune system, as in autoimmune diseases. Some people are born with intrinsic defects in their immune system, or primary immunodeficiency.A person who has an immunodeficiency of any kind is said to be immunocompromised. An immunocompromised individual may particularly be vulnerable to opportunistic infections, in addition to normal infections that could affect anyone. It also decreases cancer immunosurveillance, in which the immune system scans the body's cells and kills neoplastic ones.

Browse All Tags